Effect of the parvovirus H-1 non-structural protein NS1 on the tumorigenicity of human gastric cancer cells

Journal of Digestive Diseases

Volumn 13, Issue 7, 2012, Pages 366-373

  Wang, Yuan Yuan ^a   Liu, Jiong ^c   Zheng, Qing ^a   Ran, Zhi Hua ^a   Salomé, Nathalie ^d   Vogel, Michèle ^d   Rommelaere, Jean ^d   Xiao, Shu Dong ^a   Wang, Zheng ^b  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b BEIJING HOSPITAL   (China)

^c JINLING HOSPITAL   (China)

^d GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Gastric neoplasms; H 1 parvovirus; Neoplastic stem cell; NS1 protein; Tumorigenicity

Indexed keywords

NONSTRUCTURAL PROTEIN 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL; CARCINOGENICITY; CONTROLLED STUDY; FEMALE; GENETIC TRANSCRIPTION; H-1 PARVOVIRUS; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECOMBINANT PLASMID; STOMACH CANCER; TUMOR XENOGRAFT;

ANIMALS; ANTIGENS, CD44; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; GENE THERAPY; GENETIC VECTORS; HUMANS; MICE; MICE, NUDE; NEOPLASM PROTEINS; NEOPLASM TRANSPLANTATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STOMACH NEOPLASMS; TRANSFECTION; TRANSPLANTATION, HETEROLOGOUS; VIRAL NONSTRUCTURAL PROTEINS;

EID: 84862669375     PISSN: 17512972     EISSN: 17512980     Source Type: Journal    
DOI: 10.1111/j.1751-2980.2012.00601.x     Document Type: Article

References (26)

1. Sasako M, Inoue M, Lin JT, Khor C, Yang HK, Ohtsu A. Gastric Cancer Working Group report. Jpn J Clin Oncol 2010; 40 Suppl 1: i28-37.
2. Nakao A, Kasuya H, Sahin TT etal. A phase I dose-escalation clinical trial of intraoperative direct intratumoral injection of HF10 oncolytic virus in non-resectable patients with advanced pancreatic cancer. Cancer Gene Ther 2011; 18: 167-75.
3. Cherry T, Longo SL, Tovar-Spinoza Z, Post DE. Second-generation HIF-activated oncolytic adenoviruses with improved replication, oncolytic, and antitumor efficacy. Gene Ther 2010; 17: 1430-41.
4. Angelova AL, Aprahamian M, Balboni G etal. Oncolytic rat parvovirus H-1PV, a candidate for the treatment of human lymphoma: in vitro and in vivo studies. Mol Ther 2009; 17: 1164-72.
5. Tattersall P. The evolution of parvoviral taxonomy. In: Kerr JR, Cotmore SF, Bloom ME, Linden RM, Parrish CR, eds. The Parvoviruses. London: Hodder Arnold, 2006: 5-14.
6. Tattersall P, Gardiner EM. Autonomous parvovirus host-cell interactions. In: Tijissen P, ed. Handbook of Parvoviruses. Boca Raton, FL: CRC Press, 1990: 111-21.
7. Cornelis JJ, Lang SI, Stroh-Dege AY, Balboni G, Dinsart C, Rommelaere J. Cancer gene therapy through autonomous parvovirus-mediated gene transfer. Curr Gene Ther 2004; 4: 249-61.
8. Muharram G, Le Rhun E, Loison I etal. Parvovirus H-1 induces cytopathic effects in breast carcinoma-derived cultures. Breast Cancer Res Treat 2010; 121: 23-33.
9. Moehler M, Blechacz B, Weiskopf N etal. Effective infection, apoptotic cell killing and gene transfer of human hepatoma cells but not primary hepatocytes by parvovirus H1 and derived vectors. Cancer Gene Ther 2001; 8: 158-67.
10. Cotmore SF, Tattersall P. Parvoviral host range and cell entry mechanisms. Adv Virus Res 2007; 70: 183-232.
11. Hristov G, Krämer M, Li J etal. Through its nonstructural protein NS1, parvovirus H-1 induces apoptosis via accumulation of reactive oxygen species. J Virol 2010; 84: 5909-22.
12. Ran ZH, Liu J, Feng Y, Zou J, Xiao SD. Investigation of the sensitivities of distinct gastric cancer cells to parvovirus H-1 induced cytotoxicity. Chin J Dig Dis 2004; 5: 93-7.
13. Faisst S, Faisst SR, Dupressoir T etal. Isolation of a fully infectious variant of parvovirus H-1 supplanting the standard strain in human cells. J Virol 1995; 69: 4538-43.
14. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74-108.
15. Cornelis JJ, Spruyt N, Spegelaere P etal. Sensitization of transformed rat fibroblasts to killing by parvovirus minute virus of mice correlates with an increase in viral gene expression. J Virol 1988; 62: 3438-44.
16. Cornelis JJ, Becquart P, Duponchel N etal. Transformation of human fibroblasts by ionizing radiation, a chemical carcinogen, or simian virus 40 correlates with an increase in susceptibility to the autonomous parvoviruses H-1 virus and minute virus of mice. J Virol 1988; 62: 1679-86.
17. Nüesch JP, Rommelaere J. NS1 interaction with CKIIα: novel protein complex mediating parvovirus-induced cytotoxicity. J Virol 2006; 80: 4729-39.
18. Corbau R, Duverger V, Rommelaere J, Nüesch JP. Regulation of MVM NS1 by protein kinase C: impact of mutagenesis at consensus phosphorylation sites on replicative functions and cytopathic effects. Virology 2000; 278: 151-67.
19. Liu J, Ran ZH, Xiao SD, Rommelaere J. Changes in gene expression profiles induced by parvovirus H-1 in human gastric cancer cells. Chin J Dig Dis 2005; 6: 72-81.
20. Corbau R, Salom N, Rommelaere J, Nüesch JP. Phosphorylation of the viral nonstructural protein NS1 during MVMp infection of A9 cells. Virology 1999; 259: 402-15.
21. Anouja F, Wattiez R, Mousset S, Caillet-Fauquet P. The cytotoxicity of the parvovirus minute virus of mice nonstructural protein NS1 is related to changes in the synthesis and phosphorylation of cell proteins. J Virol 1997; 71: 4671-8.
22. Nüesch JP, Rommelaere J. A viral adaptor protein modulating casein kinase II activity induces cytopathic effects in permissive cells. Proc Natl Acad Sci U S A 2007; 104: 12482-7.
23. Ghaffarzadehgan K, Jafarzadeh M, Raziee HR etal. Expression of cell adhesion molecule CD44 in gastric adenocarcinoma and its prognostic importance. World J Gastroenterol 2008; 14: 6376-81.
24. Kakarala M, Wicha MS. Cancer stem cells: implications for cancer treatment and prevention. Cancer J 2007; 13: 271-5.
25. Ailles LE, Weissman IL. Cancer stem cells in solid tumors. Curr Opin Biotechnol 2007; 18: 460-6.
26. Takaishi S, Okumura T, Tu S etal. Identification of gastric cancer stem cells using the cell surface marker CD44. Stem Cells 2009; 27: 1006-20.